Literature DB >> 11819382

Detection of serum TNF-alpha,IFN-beta,IL-6 and IL-8 in patients with hepatitis B.

Jing-Yan Wang, Xue-Lian Wang, Pei Liu.   

Abstract

AIM:To assess the possible roles of cytokines (TNF-alpha, IFN-beta, IL-6 and IL-8) in liver damage of hepatitis B.
METHODS: The serum TNF-alpha, IFN-beta, IL-6 and IL-8 were detected by ELISA in 66 patients with hepatitis B and 20 healthy blood donors.
RESULTS: TNF-alpha and IL-6 in all types of clinical hepatitis B were significantly higher than those in healthy blood donors (P < 0.05); meanwhile the levels of TNF-alpha, IFN-beta, IL-6 and IL-8 in the patients with fulminant hepatitis B were much higher than those in the patients with acute hepatitis B (P < 0.05); the level of TNF-alpha was positively correlated with the levels of IFN-beta, Il-6 and IL-8 in all types of hepatitis B (r(IFN) = 0.24,r(IL6) = 0.35,r(IL8) = 0.44) and the TNF-alpha, IFN-beta, IL-6 and IL-8 were positively correlated with serum bilirubin (P < 0.05). Dynamic changes of these cytokines were observed in the course of acute and fulminant hepatitis. The level of IFN-beta peaked in the initial period of acute hepatitis and early stage of hepatic coma in fulminant hepatitis; TNF-alpha, IL-6 and IL-8 increased with exacerbation, and reached a peak when the liver damage was most serious, then decreased when patient conditions were improved.
CONCLUSION: The increased cytokines were related to the inflammation of liver cells and multiple factors may play certain roles in liver damage.

Entities:  

Year:  1999        PMID: 11819382      PMCID: PMC4688496          DOI: 10.3748/wjg.v5.i1.38

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  7 in total

1.  Detection by in situ hybridization and phenotypic characterization of cells expressing IL-6 mRNA in human stimulated blood.

Authors:  K Kato; T Yokoi; N Takano; H Kanegane; A Yachie; T Miyawaki; N Taniguchi
Journal:  J Immunol       Date:  1990-02-15       Impact factor: 5.422

2.  Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor.

Authors:  C G Larsen; A O Anderson; J J Oppenheim; K Matsushima
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

3.  Enhanced tumor necrosis factor and interleukin-1 in an experimental model of massive liver cell necrosis/fatal hepatitis in mice.

Authors:  P Liu; H Ohnishi; H Moriwaki; Y Muto
Journal:  Gastroenterol Jpn       Date:  1990-06

4.  Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice.

Authors:  L G Guidotti; K Ando; M V Hobbs; T Ishikawa; L Runkel; R D Schreiber; F V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

5.  Role of mononuclear infiltrating cells in pathogenesis of hepatitis.

Authors:  J Ferluga; A C Allison
Journal:  Lancet       Date:  1978-09-16       Impact factor: 79.321

6.  Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure.

Authors:  Y Muto; K T Nouri-Aria; A Meager; G J Alexander; A L Eddleston; R Williams
Journal:  Lancet       Date:  1988-07-09       Impact factor: 79.321

7.  Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor.

Authors:  K Matsushima; K Morishita; T Yoshimura; S Lavu; Y Kobayashi; W Lew; E Appella; H F Kung; E J Leonard; J J Oppenheim
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

  7 in total
  20 in total

1.  Plasma endothelin in patients with endotoxemia and dynamic comparison between vasoconstrictor and vasodilator in cirrhotic patients.

Authors:  F Liu; J X Li; C M Li; X S Leng
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  Protective effects of cyclosporine A on T-cell dependent ConA-induced liver injury in Kunming mice.

Authors:  X L Zhang; Q Z Quan; Z Q Sun; Y J Wang; X L Jiang; D Wang; W B Li
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

3.  Influence of granulocyte macrophage colony stimulating factor and tumor necrosis factor on anti-hepatoma activities of human dendritic cells.

Authors:  Jin-Kun Zhang; Jin-Lun Sun; Hai-Bin Chen; Yang Zeng; Yao-Jun Qu
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

4.  The role of endotoxin, TNF-alpha, and IL-6 in inducing the state of growth hormone insensitivity.

Authors:  Ping Wang; Ning Li; Jie-Shou Li; Wei-Qin Li
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

5.  Animal experiment and clinical study of effect of gamma-interferon on hepatic fibrosis.

Authors:  H L Weng; W M Cai; R H Liu
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

6.  Inhibition of hepatitis B virus by oxymatrine in vivo.

Authors:  X S Chen; G J Wang; X Cai; H Y Yu; Y P Hu
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

7.  Multiplex serum cytokine immunoassay using nanoplasmonic biosensor microarrays.

Authors:  Pengyu Chen; Meng Ting Chung; Walker McHugh; Robert Nidetz; Yuwei Li; Jianping Fu; Timothy T Cornell; Thomas P Shanley; Katsuo Kurabayashi
Journal:  ACS Nano       Date:  2015-03-23       Impact factor: 15.881

8.  Macrophage scavenger receptor 1 contributes to pathogenesis of fulminant hepatitis via neutrophil-mediated complement activation.

Authors:  Yuan Tang; Huifang Li; Junru Li; Yunzhi Liu; Yanli Li; Jing Zhou; Jia Zhou; Xiao Lu; Wei Zhao; Jinlin Hou; Xiang-Yang Wang; Zhengliang Chen; Daming Zuo
Journal:  J Hepatol       Date:  2017-11-14       Impact factor: 25.083

Review 9.  TLR3 plays significant roles against hepatitis B virus.

Authors:  Masoud Karimi-Googheri; Mohammad Kazemi Arababadi
Journal:  Mol Biol Rep       Date:  2014-01-30       Impact factor: 2.316

10.  Tumor necrosis factor-alpha-induced reduction of glomerular filtration rate in rats with fulminant hepatic failure.

Authors:  Jing-Bo Wang; Dong-Lei Wang; Hai-Tao Wang; Zhao-Han Wang; Ying Wen; Cui-Ming Sun; Yi-Tong Zhao; Jian Wu; Pei Liu
Journal:  Lab Invest       Date:  2014-06-02       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.